Human leucocyte antigen in variant angina

International Journal of Cardiology

Volumn 14, Issue 1, 1987, Pages 47-53

  Numano, Fujio ^a   Nomura, Shuzo ^a   Yajima, Michiyoshi ^a   Aizawa, Tadanori ^b   Fujii, Jun ichi ^b   Kishida, Hiroshi ^c   Hayakawa, Koh ichi ^c   Sasazuki, Takehiko ^d  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b THE CARDIOVASCULAR INSTITUTE   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Genetic factor; Human leucocyte antigen; Variant angina

Indexed keywords

HLA ANTIGEN;

BLOOD AND HEMOPOIETIC SYSTEM; CONTROLLED STUDY; CORONARY ARTERY SPASM; DIAGNOSIS; HEART; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; VARIANT ANGINA PECTORIS;

ANGINA PECTORIS, VARIANT; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; FEMALE; HISTOCOMPATIBILITY ANTIGENS; HUMANS; JAPAN; MALE;

EID: 0023197389     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(87)90177-X     Document Type: Article

References (46)

1. Vascoconstrictors, spasm and acute myocardial events
2. Prinzmetal's variant form of angina with arteriographic evidence of coronary arterial spasm
3. Coronary artery spasm: demonstration, definition, diagnosis and consequences
4. Coronary spasm in myocardial infarction: fact or fiction?
5. The role of coronary artery spasm in acute myocardial infarction
6. Spectrum of coronary arterial spasm. Clinical, angiographic and myocardial metabolic experience in 29 cases
7. Coronary artery spasm intact dogs induced by potassium and serotonin
8. Coronary arteries of cardiac patients are hyperreactive and contain stores of amines; a mechanism for coronary spasm
9. Contribution of dynamic vascular wall thickening to luminal narrowing during coronary arterial constriction
10. Mechanisms of coronary arterial spasm
11. What causes coronary spasm? Theories and facts
12. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
13. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
14. 2
15. Coronary tone modulation; formation and action of prostaglandins, endoperoxides and thromboxanes
16. Mode of action of coronary arterial relaxation by prostacyclin
17. Prostaglandins: regulatory role in cardiovascular system and implications in ischemic heart disease
18. 2 levels in patients with classic and variant angina pectoris
19. Thromboxane release during pacing-induced angina pectoris; possible vasoconstrictor influence on the coronary vasculature
20. 2 blockade to prevent attacks of vasospastic angina
21. Effects of intravenous prostacyclin in variant angina
22. 2 in vasotonic angina pectoris
23. Coronary spasm, prostaglandins and HLA factors
24. Prostaglandins in variant angina
25. Prinzmetal's variant angina; Is it transmitted genetically?
26. Second Asia-Oceania Histocompatibility Workshop conference
27. Population analysis of HLA A, B, C, DR and other genetic markers
28. A variant form of angina pectoris; preliminary report
29. Pathophysiology of coronary artery spasm
30. The injury-spasm and vascular autoregulatory hypothesis of ischemic disease
31. Frequency of provoked arterial spasm in 1809 consecutive patients undergoing coronary arteriography
32. Coronary artery spasm induced in atherosclerosis miniature swine
33. Selective hypercontraction caused by ergonovine in the canine coronary artery under conditions of induced atherosclerosis
34. Supersensitivity of Atherosclerotic Rabbit Aorta to Ergonovine
35. Contractions in normal and atherosclerotic rabbit aortas
36. Clinical syndrome of variant angina with normal coronary arteriogram
37. Variant angina pectoris caused by coronary artery spasm
38. Epidemiological studies on coronary spasm
39. Prinzmetal's variant form of angina pectoris, re-evaluation of mechanisms
40. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.
41. HLA-DRω4 antigen linkage in patients with hypertrophic obstructive cardiomyophathy
42. [The polymorphisms of HTC-defined HLA specificities in the Shanghai Chinese population].
43. HL-A Antigens in Thromboangiitis Obliterans
44. Evidence for an HLA-Linked Resistance Gene in Buerger's Disease
45. HLA antigens in Takayasu's disease
46. Four common HLA haplotype and their association with disease in the Japanese population